Home > Boards > US Listed > Medical - Drugs > Horizon Pharma, Inc. (HZNP)

* * $HZNP Video Chart 05-08-17 * *

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ClayTrader Member Profile
Member Level 
Followed By 8,631
Posts 187,477
Boards Moderated 4
Alias Born 12/27/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/15/2019 4:20:48 PM
FORTUNE and Great Place to Work® Name Horizon Therapeutics plc to Best Workplaces for Parents List Business Wire - 11/14/2019 9:30:00 AM
Horizon Therapeutics plc to Participate in Upcoming Investor Conferences Business Wire - 11/13/2019 4:15:00 PM
Data from Uncontrolled Gout Case Series Supports Immunomodulation with KRYSTEXXA® (pegloticase injection) Strategy to Optimi... Business Wire - 11/11/2019 8:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:09:01 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:08:31 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:07:45 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:07:10 PM
The Chicago Tribune Names Horizon Therapeutics plc a 2019 Top Workplace Business Wire - 11/8/2019 9:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/7/2019 4:40:06 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2019 7:18:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 7:08:35 AM
Horizon Therapeutics plc Reports Strong Third-Quarter 2019 Results Business Wire - 11/6/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 5:04:57 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/5/2019 5:02:43 PM
Horizon Therapeutics plc Brings Gout-Kidney Link into Focus during American Society of Nephrology (ASN) Kidney Week 2019 Business Wire - 11/5/2019 8:00:00 AM
Clinical Study Data Highlighting the Impact of Teprotumumab in Patients With Active Thyroid Eye Disease to Be Presented Durin... Business Wire - 11/4/2019 8:30:00 AM
New Evidence on the Burden of Gout to be Featured in Data Presentations at Upcoming ACR Annual Meeting Business Wire - 11/4/2019 8:00:00 AM
Integrated Clinical Trial Analyses Further Substantiate that Teprotumumab Significantly Improves Debilitating Effects of Thyr... Business Wire - 10/31/2019 10:00:00 AM
Horizon Therapeutics plc Named One of the Most Innovative Companies by Crain’s Chicago Business Business Wire - 10/24/2019 11:15:00 AM
New Combined Data from the Phase 2 & Phase 3 Teprotumumab Clinical Trials to be Presented during the American Thyroid Associa... Business Wire - 10/24/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/17/2019 4:43:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/17/2019 4:42:08 PM
FORTUNE & Great Place to Work® Name Horizon Therapeutics plc to Best Small & Medium Workplaces List for Fourth Consecutive Y... Business Wire - 10/17/2019 9:00:00 AM
Horizon Therapeutics plc Initiates PROTECT Trial Evaluating KRYSTEXXA® (pegloticase injection) to Improve Management of Unco... Business Wire - 10/17/2019 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist